University Hospital Tuebingen

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1388-01-01

Employees: -

Market Cap: -

Website: https://www.klinikum.uni-heidelberg.de/Startseite.2.0.html?&no_cache=1

Clinical Trials

How Fat Influences the Brain

Not Applicable

Completed

Conditions: Fat Processing in the Brain

Interventions: Dietary Supplement: intake of high or low fat yoghurt

First Posted Date: 2012-01-24

Last Posted Date: 2012-01-24

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 11

Registration Number: NCT01516021

Locations: 🇩🇪
University Clinic of Tuebingen, MEG Center, Tuebingen, Germany

A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2

Phase 2

Completed

Conditions: Malignant Melanoma

Interventions: Drug: Interleukin-2
Drug: Ipilimumab

First Posted Date: 2011-11-28

Last Posted Date: 2015-07-21

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 15

Registration Number: NCT01480323

Locations: 🇩🇪
University Hospital Tübingen, Tübingen, Germany

Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations

Phase 2

Completed

Conditions: Auditory Hallucinations

Interventions: Procedure: continuous theta burst stimulation (cTBS)
Procedure: sham cTBS

First Posted Date: 2011-11-23

Last Posted Date: 2013-07-16

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 16

Registration Number: NCT01478880

Locations: 🇩🇪
University of Tübingen, Department of Psychiatry and Psychotherapy, Tübingen, Germany

Monocentric Registry to Investigate the Role of Platelet Function, Platelet Genetics, Proteomics and Metabonomics in Heart Disease

Recruiting

Conditions: Cardiovascular Disease

First Posted Date: 2011-08-16

Last Posted Date: 2018-10-15

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 3000

Registration Number: NCT01417884

Locations: 🇩🇪
Medizinische Klinik und Poliklinik Tübingen, Cardiology Department, University Hospital Tübingen, Tübingen, Baden Wuerttemberg, Germany

Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants

Phase 4

Completed

Conditions: Anemia of Prematurity

Interventions: Other: red blood cell transfusion

First Posted Date: 2011-07-13

Last Posted Date: 2021-09-16

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 1013

Registration Number: NCT01393496

Locations: 🇩🇪
Children's Hospital, Stuttgart, Germany
🇩🇪
University Hospital of Aachen, Aachen, Germany
🇩🇰
Neonatalklinikken, Copenhagen, Denmark

and more 14 locations

T-cell-immunity During Standard Radiotherapy in Localised Prostate Cancer

Completed

Conditions: Prostate Cancer

First Posted Date: 2011-06-20

Last Posted Date: 2013-08-16

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 22

Registration Number: NCT01376674

Locations: 🇩🇪
Department of Radiation Oncology, Tuebingen, Germany

Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)

Completed

Conditions: Glaucoma

First Posted Date: 2011-06-13

Last Posted Date: 2014-05-28

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 60

Registration Number: NCT01372319

Locations: 🇩🇪
Centre for Ophthalmology University of Tübingen, Tübingen, Baden-Württemberg, Germany

Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)

Completed

Conditions: Homonymous Hemianopia

First Posted Date: 2011-06-13

Last Posted Date: 2014-05-28

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 60

Registration Number: NCT01372332

Locations: 🇩🇪
Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen, Tübingen, Baden-Württemberg, Germany

Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Device: deep brain stimulation (ACTIVA PC, Medtronic)

First Posted Date: 2011-05-18

Last Posted Date: 2012-08-08

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 12

Registration Number: NCT01355835

Locations: 🇩🇪
Center of Neurology and Hertie Institute for Clinical Brain Research, and Department for Neurodegenerative Diseases, University of Tübingen, Tübingen, Baden-Württemberg, Germany

NAM-Trial: Multiferon in Malignant Melanoma

Phase 2

Completed

Conditions: Locoregional Metastases in Malignant Melanoma Stages IIIB/C

Interventions: Drug: human interferon-α

First Posted Date: 2011-04-25

Last Posted Date: 2014-11-13

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 42

Registration Number: NCT01341158

Locations: 🇩🇪
Universitätshautklinik Tübingen, Tübingen, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy